steel column of 50ϫ4 mm ID, and used on-line as a pre-column IMER at 30°C.
Preparation of Sample Solution and Standard Solution
The preparation of both FMNs and riboflavin standard solution has also been described in detail in a previous paper. 7) The solutions were carefully preserved in light-resistant containers.
Assay of Enzyme Activity The effect of a heavy metal ion (cupric ion, Cu 2ϩ ) on the soluble acid phosphatase activity was measured as follows: 50-ml of a known concentration of cupric chloride and 20-ml of the enzyme solution were added to 0.9 ml of 0.5 M acetate buffer, pH 5.6, and then incubated for 30 min at 40°C. After incubation, the enzyme reaction was started by adding 30 ml of 0.6 M disodium p-nitrophenyl phosphate solution as a substrate. The reaction was allowed to continue for 10 min at 40°C, when 2 ml of 0.5 M NaOH was added, and then the absorbance of the liberated pnitrophenol was measured at 405 nm by a spectrophotometer using p-nitrophenol as a standard. For measurement of the recovery effects of the additives on the enzyme inhibition by Cu 2ϩ , known concentrations of additives (citrate or ethylenediaminetetraacetic acid disodium salt, EDTA) were co-incubated with cupric chloride, and assayed as described above. Enzyme activity was expressed as a percentage of that without metal ion and/or additives.
On-Line Automated Analytical System for ContinuousUse IMER A schematic diagram of the pre-column IMER/reversed-phase high-performance liquid chromatographic (HPLC) system is shown in Fig. 1 . The analytical system used throughout this study was the same as that described in a previous paper. 7) Three Shimadzu LC-6A pumps (Kyoto) and two "six-ported" switching valves (FCV-2AH, Shimadzu) were controlled by a system controller (SCL-6B, Shimadzu). Three different solutions, specifically two carrier streams, i.e., a weak solution of acetic acid (5 mM) and 0.5 M acetate buffer, pH 5.0, and a mobile phase, were pumped through the individual pumps. Sample solutions containing 1.25 nmol amounts of FMNs were injected through an automated sample injector (SIL-6B, Shimadzu) at a sample volume of 20 ml. The IMER was thermostated at 30°C. The sample solution was passed through the IMER via a carrier stream containing 0.5 M acetate buffer, pH 5.0, at a flow-rate of 0.5 ml/min, and the flow was then passed through a trap column (TSK guardgel ODS-80Ts, 15ϫ3.2 mm ID, Tosoh, Tokyo). After 10 min, the switching valve (SV) on this line, SV-2, was switched, and then the unaltered FMNs and enzymatically hydrolyzed riboflavin were back-eluted from the trap column using a mobile phase containing methanol. The mobile phase consisted of 0.1 M ammonium formate buffer, pH 3.7-methanol (73 : 27, v/v) and was pumped at a flowrate of 1.0 ml/min. FMNs and riboflavin were subsequently chromatographed on an analytical column (TSK gel ODS80Ts, 150ϫ4.6 mm ID, 5-mm particle, Tosoh), and detected by UV absorption at 280 nm with a spectrophotometer (SPD-6A) equipped with an 8-ml flow cell. The trap column and analytical column were thermostated at 50°C in a column oven (CTO-6A, Shimadzu). Chromatographic data were recorded on a Chromatopac CR-3A integrator (Shimadzu). During the period of separation and detection, the trap column was programmed to wash with 5 mM acetic acid via an opposite IMER line, i.e., a column-free line, and then buffered with 0.5 M acetate buffer, pH 5.0, for the next analysis. The time program of the on-line pre-column IMER/HPLC analytical system for the determination of total FMNs was described in detail in a previous paper.
7)
Surface Plasmon Resonance Analysis All measurements were performed on a Biacore X instrument from Biacore AB (Uppsala, Sweden). The principle and application of the system for surface plasmon resonance (SPR) detection were described by Karlsson et al. 8) Acid phosphatase was immobilized to a CM5 sensor chip via primary amine groups as described in the literature.
9) The carboxylated dextran matrix on the sensor surface was washed with HBS-EP buffer at a flow rate of 5 ml/min at 30°C, and then activated by injecting a mixture (75 ml) of 100 mM NHS and 400 mM EDC in equal volumes. In order to immobilize acid phosphatase to the activated dextran matrix, 300 ml of acid phosphatase solution at a concentration of 560 mg protein/ml (20.9 unit/mg protein) in 10 mM sodium acetate buffer, pH 4.0, was successively injected using a Biacore control program. The remaining activated NHS-ester groups were blocked by injection of 75 ml of 1 M ethanolamine hydrochloride, pH 8.5. The SPR measurements for riboflavin binding to acid phosphatase with or without citrate were performed in 10 mM sodium acetate buffer, pH 5.0, 0.15 M NaCl and 0.005% Tween 20, at a flow rate of 20 ml/min for 3 min. The sensor surface was regenerated with a 60-ml injection of 10 mM glycine-HCl buffer, pH 2.5. The rates of association (K a ) and dissociation (K d ) were determined using the BIAevaluation 3.0 software program, and the equilibrium dissociation constant (K D ) was estimated using the formula
RESULTS AND DISCUSSION
In a previous paper, we partially observed that the enzymatic conversion of FMNs to riboflavin by IMER was enhanced by the addition of certain additives. 7) When a sample solution without additives was chromatographed, a small 4Ј-FMN peak was observed on the chromatogram, but when sample solutions containing additives were analyzed, the 4Ј-FMN peak disappeared and the conversion rate increased. The conversion rate of FMNs to riboflavin by the IMER without additives was about 89%. The addition of KCl, ethanol or methanol at a final concentration in the sample solution of 150 mM and 50% for KCl and alcohols, respectively, brought the conversion rate up to 91-93%. 7) We tried to in- crease the conversion rate by adding malonate, succinate, glutarate, tartarate, lactate, malate, citrate and EDTA. Figure  2 shows the results of an experiment to measure the conversion ratio as a function of the final concentration of additives in the sample solution. Citrate, malate, EDTA and tartarate were all effective, with the addition of citrate to the sample solution being extremely effective, and a final concentration of 50 mM was sufficient. The conversion ratio increased about 1.09-fold, and the conversion rate of FMNs to riboflavin was approximately 97%. Certain phosphatases had associated phosphotransferases, which transfer the phosphate group from phosphomonoesters to suitable hydroxy compounds as phosphate acceptors.
10) The shift in the reaction equilibrium may have been the cause of the increased conversion rate. Compounds with a hydroxy group, i.e., lactate, ethanol or methanol did not substantially increase the conversion rate. The hydroxy group of citrate does not appear to be essential. Citrate has a weak chelating action, therefore, we examined the possibility of a chelating action on metals in the sample solution. A study of the activity of sweet potato acid phosphatase reported that it was inhibited by Cu for use in the assay mixture. We then attempted to measure the recovery effects of citrate and EDTA on the inhibition of the enzyme by Cu 2ϩ as described in Materials and Methods. Complete recovery was obtained at about 5ϫ10 Ϫ4 M and 4.5ϫ10 Ϫ3 M for EDTA and citrate, respectively, as shown in Fig. 3B . The effective concentration of citrate for conversion of FMNs to riboflavin was lower than that of EDTA, whereas the concentration of citrate for complete recovery of inhibition of the enzyme by Cu 2ϩ required about a 10-fold excess compared with EDTA. It was thus found that the effective addition of citrate did not result from the chelation of heavy metals in the sample solution. SPR detection allows direct observation of the molecular interaction between an analyte in solution and its immobilized binding partner, and this observation includes the monitoring of low-molecular-weight analytes and that of low affinity interactions. 12) We investigated the complex formation of acid phosphatase with the substrate FMNs using SPR in order to clarify the effect of citrate on the processes of association and/or dissociation between the enzyme and substrate. The SPR signal for immobilized acid phosphatase was found to be about 13500 resonance units (RU). The calculated maximum binding capacity, Rmax, was 64.7 RU. All independent experiments were performed over the concentration range of 0.5 mM to 2.5 mM FMNs in triplicate. The citrate/FMNs ratio was kept constant at 4. Figure 4 Ϫ3 M with a standard deviation of 2.6ϫ10 Ϫ4 M with citrate. This indicates that the K D for the acid phosphatase riboflavin phosphate complex was slightly increased by the addition of citrate. The addition of citrate to FMNs may induce a conformational change in the enzyme and make the catalytic site more easily accessible to FMNs, thereby increasing the enzymatic turnover reaction. Interestingly, the addition of citrate increased the conversion rate, although the increase was slightly different after repeated use of the IMER. The immobilized acid phosphatase was freshly packed and used in the IMER in order to determine the stability behavior of the IMER and to investigate the activation by citrate during the course of prolonged, repeated use. IMER function was evaluated using the on-line automated pre-column IMER/reversed-phase HPLC system we constructed. The IMER was thermostated at 30°C. Five samples without citrate, followed by five samples with citrate, were each continuously injected on the same day in amounts of 1.25 nmol (62.5 nmol per ml) using FMNs as a substrate, and the IMER was repeatedly used over an extremely long period of time. Therefore, sample injection was performed at ten samples per day, with 3000 samples over ten months. The change in conversion rate from FMNs to riboflavin is shown in Fig. 5 . The IMER did not require the addition of so much citrate at the beginning of use, but the effectiveness of citrate addition was gradually observed. This result also indicates that IMER activity decreased during the course of prolonged, repeated use. However, even after 1500 continuous injections of individual samples with and without citrate had been made, i.e., a sum total of 3000 samples, about 75% of its original activity remained. Chromatograms obtained during the course of repeated use are shown in Fig. 6 , in which those for the beginning, middle and end of experiments are represented. The FMN preparations used throughout this study contained 3Ј-FMN, 4Ј-FMN, 5Ј-FMN and riboflavin, in proportions of approximately 8 : 11 : 69 : 12. 4Ј-FMN was somewhat resistant to enzymatic hydrolysis (Fig. 6C ), but underwent hydrolysis after the addition of citrate (Fig. 6D) . The peak of 4Ј-FMN increased following continuous injection of the samples (Figs. 6E, G) . The peak of 4Ј-FMN did not disappear even after the addition of citrate (Figs. 6F, H) . The appearance of individual non-hydrolyzed components is illustrated clearly in Fig. 7 . As shown in Fig. 7A , 4Ј-FMN was first detected, and 3Ј-FMN subsequently appeared. 5Ј-FMN was the most susceptible FMN to the enzyme, but 5Ј-FMN appeared slowly after prolonged, repeated use. Concurrently, Fig. 7B shows that the addition of citrate suppressed the appearance of non-hydrolyzed 3Ј-, 4Ј-and 5Ј-FMNs. For example, nonhydrolyzed 3Ј-FMN appeared after 700 continuous injections of each individual sample without citrate had been made, i.e., a sum total of 1400 samples (Fig. 7A) . On the other hand, non-hydrolyzed 3Ј-FMN appeared after 900 continuous in- jections of each individual sample with citrate had been made, i.e., a sum total of 1800 samples (Fig. 7B) . This finding also suggests that the addition of citrate can retard the appearance of non-hydrolyzed FMNs. Nevertheless, enzyme fatigue due to prolonged, repeated work was observed by the end of the experiments. Even 5Ј-FMN, i. e., the most abundant and susceptible phosphate ester among FMNs, was then not completely hydrolyzed. We interpret this phenomenon to indicate enzyme fatigue.
Immobilized enzymes have been employed as model systems in studying microenvironmental effects on enzyme action, as described in a prior report by Katchalsky et al. 13) In the present study, we tested a unique immobilized enzyme application as a model system to investigate enzyme fatigue. In this manner, immobilized enzyme technology will be available in a broad range of applications in the future.
